Research Articles

Published research summaries and Q&A. All articles are for informational purposes only. Not medical advice — consult your healthcare team.

• Riluzole (Rilutek) for ALS (Amyotrophic Lateral Sclerosis) — What Published Research Shows
• Riluzole (Rilutek) for Stage IV Cancer — What Published Research Shows
• Riluzole (Rilutek) for Alzheimer's Disease — What Published Research Shows
• Riluzole (Rilutek) for Parkinson's Disease — What Published Research Shows
• Riluzole (Rilutek) for Autoimmune Diseases — What Published Research Shows
• Riluzole (Rilutek) for Prostate Cancer — What Published Research Shows
• Riluzole (Rilutek) for Ovarian Cancer — What Published Research Shows
• Riluzole (Rilutek) for Melanoma (Skin Cancer) — What Published Research Shows
• Riluzole (Rilutek) for Liver Cancer (Hepatocellular Carcinoma) — What Published Research Shows
• Riluzole (Rilutek) for Stomach Cancer (Gastric Cancer) — What Published Research Shows
• Riluzole (Rilutek) for Brain Cancer (Glioblastoma) — What Published Research Shows
• Riluzole (Rilutek) for Leukemia (Blood Cancer) — What Published Research Shows
• Riluzole (Rilutek) for Multiple Sclerosis — What Published Research Shows
• Riluzole (Rilutek) for Huntington's Disease — What Published Research Shows
• Riluzole (Rilutek) for Fibromyalgia — What Published Research Shows
• Riluzole (Rilutek) for Breast Cancer — What Published Research Shows
• Riluzole (Rilutek) for Pancreatic Cancer — What Published Research Shows
• Riluzole (Rilutek) for Colorectal Cancer — What Published Research Shows
• Riluzole (Rilutek) for Lung Cancer — What Published Research Shows
• Riluzole (Rilutek) for Type 2 Diabetes — What Published Research Shows
• Riluzole (Rilutek) for Rheumatoid Arthritis — What Published Research Shows
• Riluzole (Rilutek) for Crohn's Disease — What Published Research Shows
• Riluzole (Rilutek) for Chronic Kidney Disease — What Published Research Shows
• Riluzole (Rilutek) for Heart Failure — What Published Research Shows
• Riluzole (Rilutek) for Neuropathic Pain — What Published Research Shows
• Edaravone (Radicava) for ALS (Amyotrophic Lateral Sclerosis) — What Published Research Shows
• Edaravone (Radicava) for Stage IV Cancer — What Published Research Shows
• Edaravone (Radicava) for Alzheimer's Disease — What Published Research Shows
• Edaravone (Radicava) for Parkinson's Disease — What Published Research Shows
• Edaravone (Radicava) for Autoimmune Diseases — What Published Research Shows
• Edaravone (Radicava) for Prostate Cancer — What Published Research Shows
• Edaravone (Radicava) for Ovarian Cancer — What Published Research Shows
• Edaravone (Radicava) for Melanoma (Skin Cancer) — What Published Research Shows
• Edaravone (Radicava) for Liver Cancer (Hepatocellular Carcinoma) — What Published Research Shows
• Edaravone (Radicava) for Stomach Cancer (Gastric Cancer) — What Published Research Shows
• Edaravone (Radicava) for Brain Cancer (Glioblastoma) — What Published Research Shows
• Edaravone (Radicava) for Leukemia (Blood Cancer) — What Published Research Shows
• Edaravone (Radicava) for Multiple Sclerosis — What Published Research Shows
• Edaravone (Radicava) for Huntington's Disease — What Published Research Shows
• Edaravone (Radicava) for Fibromyalgia — What Published Research Shows
• Edaravone (Radicava) for Breast Cancer — What Published Research Shows
• Edaravone (Radicava) for Pancreatic Cancer — What Published Research Shows
• Edaravone (Radicava) for Colorectal Cancer — What Published Research Shows
• Edaravone (Radicava) for Lung Cancer — What Published Research Shows
• Edaravone (Radicava) for Type 2 Diabetes — What Published Research Shows
• Edaravone (Radicava) for Rheumatoid Arthritis — What Published Research Shows
• Edaravone (Radicava) for Crohn's Disease — What Published Research Shows
• Edaravone (Radicava) for Chronic Kidney Disease — What Published Research Shows
• Edaravone (Radicava) for Heart Failure — What Published Research Shows
• Edaravone (Radicava) for Neuropathic Pain — What Published Research Shows
• Relyvrio (AMX0035) for ALS (Amyotrophic Lateral Sclerosis) — What Published Research Shows
• Relyvrio (AMX0035) for Stage IV Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Alzheimer's Disease — What Published Research Shows
• Relyvrio (AMX0035) for Parkinson's Disease — What Published Research Shows
• Relyvrio (AMX0035) for Autoimmune Diseases — What Published Research Shows
• Relyvrio (AMX0035) for Prostate Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Ovarian Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Melanoma (Skin Cancer) — What Published Research Shows
• Relyvrio (AMX0035) for Liver Cancer (Hepatocellular Carcinoma) — What Published Research Shows
• Relyvrio (AMX0035) for Stomach Cancer (Gastric Cancer) — What Published Research Shows
• Relyvrio (AMX0035) for Brain Cancer (Glioblastoma) — What Published Research Shows
• Relyvrio (AMX0035) for Leukemia (Blood Cancer) — What Published Research Shows
• Relyvrio (AMX0035) for Multiple Sclerosis — What Published Research Shows
• Relyvrio (AMX0035) for Huntington's Disease — What Published Research Shows
• Relyvrio (AMX0035) for Fibromyalgia — What Published Research Shows
• Relyvrio (AMX0035) for Breast Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Pancreatic Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Colorectal Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Lung Cancer — What Published Research Shows
• Relyvrio (AMX0035) for Type 2 Diabetes — What Published Research Shows
• Relyvrio (AMX0035) for Rheumatoid Arthritis — What Published Research Shows
• Relyvrio (AMX0035) for Crohn's Disease — What Published Research Shows
• Relyvrio (AMX0035) for Chronic Kidney Disease — What Published Research Shows
• Relyvrio (AMX0035) for Heart Failure — What Published Research Shows
• Relyvrio (AMX0035) for Neuropathic Pain — What Published Research Shows
• Masitinib for ALS (Amyotrophic Lateral Sclerosis) — What Published Research Shows
• Masitinib for Stage IV Cancer — What Published Research Shows
• Masitinib for Alzheimer's Disease — What Published Research Shows
• Masitinib for Parkinson's Disease — What Published Research Shows
• Masitinib for Autoimmune Diseases — What Published Research Shows
• Masitinib for Prostate Cancer — What Published Research Shows
• Masitinib for Ovarian Cancer — What Published Research Shows
• Masitinib for Melanoma (Skin Cancer) — What Published Research Shows
• Masitinib for Liver Cancer (Hepatocellular Carcinoma) — What Published Research Shows
• Masitinib for Stomach Cancer (Gastric Cancer) — What Published Research Shows
• Masitinib for Brain Cancer (Glioblastoma) — What Published Research Shows
• Masitinib for Leukemia (Blood Cancer) — What Published Research Shows
• Masitinib for Multiple Sclerosis — What Published Research Shows
• Masitinib for Huntington's Disease — What Published Research Shows
• Masitinib for Fibromyalgia — What Published Research Shows
• Masitinib for Breast Cancer — What Published Research Shows
• Masitinib for Pancreatic Cancer — What Published Research Shows
• Masitinib for Colorectal Cancer — What Published Research Shows
• Masitinib for Lung Cancer — What Published Research Shows
• Masitinib for Type 2 Diabetes — What Published Research Shows
• Masitinib for Rheumatoid Arthritis — What Published Research Shows
• Masitinib for Crohn's Disease — What Published Research Shows
• Masitinib for Chronic Kidney Disease — What Published Research Shows
• Masitinib for Heart Failure — What Published Research Shows
• Masitinib for Neuropathic Pain — What Published Research Shows